Edition:
United States

ClinicalTrials.gov says Janssen's study of niraparib suspends recruitment


Friday, 9 Jun 2017 10:54am EDT 

June 9 (Reuters) - ClinicalTrials.gov::Janssen Research's study of niraparib in men with metastatic castration-resistant prostate cancer, DNA-repair anomalies suspended recruitment.Current participants in Janssen Research's study of niraparib remain active and on study treatment.